Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 8,018 | 8,526 | 7,048 |
| Operating Income | -8,018 | -8,526 | -7,048 |
| Interest Expense | -166 | 3,456 | 10 |
| Pre-tax Income | -7,853 | -11,982 | -7,058 |
| Net Income Continuous | -7,853 | -11,982 | -7,058 |
| Net Income | $-7,853 | $-11,982 | $-7,058 |
| EPS Basic Total Ops | -0.51 | -0.85 | -0.40 |
| EPS Basic Continuous Ops | -0.51 | -0.86 | -0.40 |
| EPS Diluted Total Ops | -0.51 | -0.85 | -0.40 |
| EPS Diluted Continuous Ops | -0.51 | -0.86 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.64 | N/A |
| EBITDA(a) | $-8,018 | $-8,526 | $-7,048 |